DMIIU
Drugs Made In America Acquisition II Corp. UnitNASDAQNONENONE
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
—
52W High
$0.00
52W Low
$0.00
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Drugs Made In America Acquisition II Corp. Unit
Drugs Made In America Acquisition II Corp. (DMIIU) is a special purpose acquisition company (SPAC) focused on merging with and supporting businesses in the pharmaceutical and biotechnology sectors. The company aims to enhance domestic drug manufacturing and catalyze innovation in healthcare through strategic investments in high-potential firms with disruptive technologies and strong operational capabilities. By addressing pressing challenges within the industry, DMIIU is positioned to create significant shareholder value while playing a pivotal role in the transformation of the American healthcare ecosystem.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
2.97%
HV 20-Day
2.19%
HV 30-Day
1.95%
HV 60-Day
1.88%
HV Rank
—
Volatility is currently expanding
More NONE Stocks
SOJESouthern Company (The) Series 2DTGDTE Energy Company 2021 Series EDTBDTE Energy Company 2020 SeriesCGABLThe Carlyle Group Inc. 4.625% Subordinated Notes due 2061MGRBAffiliated Managers Group, Inc.UZFArray Digital Infrastructure, IUZDArray Digital Infrastructure, INIQNIQ Global Intelligence plcRILYTB. Riley Financial Inc. 6.00% Senior Notes Due 2028HWCPZHancock Whitney Corporation - 6OXLCLOxford Lane Capital Corp. 6.75% Notes due 2031BBBYBed Bath & Beyond, Inc.
Data last updated: 5/25/2026